LOMUSTINE

LOMUSTINE was reported 2597 times

LOMUSTINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III 5 0.2778
1 ASTROCYTOMA SURGERY 1 0.2000
2 GAMMA RADIATION THERAPY 4 0.1600
3 MYXOID LIPOSARCOMA 4 0.1176
4 CARDIAC VALVE THICKENING 4 0.0678
5 CYTOMEGALOVIRUS URINARY TRACT INFECTION 2 0.0645
6 HYPERMUTATION 9 0.0643
7 ISOCITRATE DEHYDROGENASE GENE MUTATION 1 0.0588
8 ASTROCYTOMA MALIGNANT 6 0.0583
9 GLIOSARCOMA 2 0.0571
10 MALIGNANT GLIOMA 7 0.0493
11 AEROMONAS INFECTION 9 0.0476
12 RADIATION MYELOPATHY 2 0.0435
13 HODGKIN'S DISEASE RECURRENT 1 0.0417
14 BRAIN RADIATION NECROSIS 3 0.0405
15 CEREBROSPINAL FLUID DRAINAGE 1 0.0385
16 PRIMITIVE NEUROECTODERMAL TUMOUR 2 0.0370
17 MEDULLOBLASTOMA 5 0.0336
18 TP53 GENE MUTATION 3 0.0309
19 ANAPLASTIC ASTROCYTOMA 5 0.0303
20 ADRENAL CORTICAL INSUFFICIENCY 1 0.0303
21 ASTROCYTOMA, LOW GRADE 5 0.0294
22 GEOTRICHUM INFECTION 6 0.0284
23 KARYOTYPE ANALYSIS ABNORMAL 3 0.0275
24 MEDULLOBLASTOMA RECURRENT 3 0.0265
25 RADIATION NECROSIS 15 0.0262
26 GLOSSOPHARYNGEAL NERVE PARALYSIS 1 0.0233
27 TUMOUR PSEUDOPROGRESSION 25 0.0228
28 CHROMOPHOBE RENAL CELL CARCINOMA 1 0.0222
29 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 27 0.0217
30 GLIOBLASTOMA 37 0.0217
31 BIFASCICULAR BLOCK 4 0.0214
32 GANGLIOGLIOMA 1 0.0208
33 LARGE GRANULAR LYMPHOCYTOSIS 7 0.0208
34 ASPERGILLOMA 6 0.0187
35 CEREBELLAR TUMOUR 2 0.0159
36 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
37 GASTRIC ADENOMA 1 0.0152
38 CENTRAL HYPOTHYROIDISM 5 0.0151
39 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 2 0.0148
40 HAEMOGLOBIN URINE PRESENT 3 0.0148
41 ENDOTOXIC SHOCK 1 0.0145
42 CARDIAC NEOPLASM MALIGNANT 1 0.0141
43 ALLERGIC TRANSFUSION REACTION 2 0.0132
44 SACCADIC EYE MOVEMENT 2 0.0120
45 POST PROCEDURAL DIARRHOEA 6 0.0118
46 ADRENOCORTICAL CARCINOMA 1 0.0114
47 ENCEPHALITIS FUNGAL 1 0.0111
48 ACUTE MONOCYTIC LEUKAEMIA 2 0.0110
49 CEREBRAL HYPERPERFUSION SYNDROME 1 0.0110
50 MICROANGIOPATHY 10 0.0106
51 ACUTE MOTOR AXONAL NEUROPATHY 1 0.0096
52 URAEMIC ENCEPHALOPATHY 3 0.0096
53 PERICARDITIS CONSTRICTIVE 4 0.0095
54 LIPOSARCOMA 3 0.0094
55 GLIOMA 6 0.0093
56 OTOTOXICITY 17 0.0092
57 CSF VOLUME INCREASED 1 0.0084
58 ABSCESS BACTERIAL 3 0.0083
59 LACRIMATION DISORDER 1 0.0082
60 MYCOBACTERIUM CHELONAE INFECTION 6 0.0081
61 ACUTE MYELOMONOCYTIC LEUKAEMIA 2 0.0079
62 MAGNETIC RESONANCE IMAGING 1 0.0078
63 CHRONIC MYELOMONOCYTIC LEUKAEMIA 5 0.0076
64 XERODERMA 2 0.0075
65 ECTHYMA 3 0.0075
66 MEAN PLATELET VOLUME DECREASED 6 0.0072
67 GLIOBLASTOMA MULTIFORME 6 0.0071
68 EPENDYMOMA 1 0.0069
69 TRANSAMINASES ABNORMAL 4 0.0069
70 EPIPHYSES PREMATURE FUSION 2 0.0066
71 BRAIN STEM GLIOMA 1 0.0066
72 5Q MINUS SYNDROME 1 0.0063
73 URINARY SEDIMENT PRESENT 4 0.0062
74 HYPERMAGNESAEMIA 4 0.0061
75 GASTROINTESTINAL POLYP 2 0.0060
76 CHOLURIA 2 0.0059
77 FAECAL VOLUME INCREASED 3 0.0058
78 MANUFACTURING PRODUCT SHIPPING ISSUE 3 0.0055
79 IIIRD NERVE PARESIS 1 0.0055
80 INTESTINAL MUCOSAL HYPERTROPHY 1 0.0055
81 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
82 PNEUMONIA CRYPTOCOCCAL 5 0.0053
83 ALVEOLAR LUNG DISEASE 1 0.0053
84 HEMIPARAESTHESIA 2 0.0051
85 BAND NEUTROPHIL COUNT INCREASED 1 0.0051
86 BONE MARROW TOXICITY 6 0.0051
87 GRANULOCYTES ABNORMAL 1 0.0050
88 CD8 LYMPHOCYTES DECREASED 1 0.0050
89 MEAN PLATELET VOLUME INCREASED 3 0.0050
90 GRANULOCYTE COUNT INCREASED 2 0.0049
91 LYMPHOCYTE PERCENTAGE INCREASED 2 0.0049
92 MEAN CELL HAEMOGLOBIN INCREASED 8 0.0048
93 IMPLANTATION COMPLICATION 1 0.0048
94 IRIS HYPERPIGMENTATION 1 0.0048
95 HALLUCINATION, OLFACTORY 2 0.0046
96 INTESTINAL FIBROSIS 1 0.0046
97 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
98 PERIPHERAL MOTOR NEUROPATHY 6 0.0043
99 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
100 CEREBRAL MICROANGIOPATHY 1 0.0042
101 VASOGENIC CEREBRAL OEDEMA 3 0.0042
102 BLOOD BICARBONATE INCREASED 2 0.0042
103 RED BLOOD CELLS URINE POSITIVE 4 0.0041
104 BLOOD LUTEINISING HORMONE INCREASED 1 0.0041
105 BRAIN STEM SYNDROME 3 0.0040
106 INCISION SITE DISCHARGE 1 0.0040
107 CHROMOSOME ANALYSIS ABNORMAL 1 0.0039
108 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
109 NEUTROPHIL PERCENTAGE DECREASED 2 0.0038
110 CEREBRAL CALCIFICATION 1 0.0037
111 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
112 ANTITHROMBIN III DECREASED 1 0.0037
113 ABDOMINAL WOUND DEHISCENCE 1 0.0037
114 DEAFNESS NEUROSENSORY 12 0.0036
115 SYSTEMIC INFECTION 6 0.0036
116 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
117 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
118 PRECOCIOUS PUBERTY 2 0.0035
119 ENGRAFT FAILURE 1 0.0035
120 SPINAL CORD NEOPLASM 3 0.0034
121 INTESTINAL PSEUDO-OBSTRUCTION 3 0.0034
122 PROTEIN URINE 3 0.0033
123 DECREASED EYE CONTACT 1 0.0033
124 ERYTHROPOIESIS ABNORMAL 1 0.0033
125 PLATELET DISORDER 8 0.0032
126 HEPATIC VEIN THROMBOSIS 1 0.0032
127 HAEMATOLOGY TEST ABNORMAL 1 0.0031
128 COLORECTAL ADENOMA 1 0.0031
129 BLOOD OSMOLARITY INCREASED 1 0.0030
130 SECOND PRIMARY MALIGNANCY 24 0.0029
131 ADMINISTRATION SITE BRUISE 1 0.0029
132 URINE LEUKOCYTE ESTERASE POSITIVE 2 0.0029
133 HAEMATOTOXICITY 27 0.0028
134 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
135 LYMPHOCYTOSIS 6 0.0028
136 ENTEROBACTER SEPSIS 1 0.0027
137 ACUTE MYELOID LEUKAEMIA 42 0.0027
138 DISSEMINATED CRYPTOCOCCOSIS 2 0.0026
139 INTELLECTUAL DISABILITY 4 0.0026
140 ILEITIS 1 0.0026
141 MACROCYTOSIS 3 0.0026
142 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
143 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 1 0.0026
144 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 2 0.0026
145 APLASIA 5 0.0026
146 NECROTISING FASCIITIS 9 0.0026
147 CENTRAL NERVOUS SYSTEM LEUKAEMIA 1 0.0025
148 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 1 0.0025
149 ASTROCYTOMA 1 0.0025
150 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 6 0.0025
151 GROWTH HORMONE DEFICIENCY 1 0.0025
152 BRAIN NEOPLASM MALIGNANT 11 0.0025
153 FEBRILE CONVULSION 3 0.0025
154 MONOCYTE COUNT DECREASED 3 0.0025
155 CRANIOTOMY 1 0.0024
156 BLOOD COUNT ABNORMAL 37 0.0024
157 NEUTROPENIC COLITIS 5 0.0024
158 FUNGAL SEPSIS 2 0.0024
159 OESOPHAGEAL RUPTURE 2 0.0024
160 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
161 GLUCOCORTICOID DEFICIENCY 1 0.0024
162 ENZYME LEVEL INCREASED 2 0.0024
163 APPARENT LIFE THREATENING EVENT 1 0.0024
164 MEAN CELL VOLUME INCREASED 6 0.0023
165 HEPATITIS CHOLESTATIC 14 0.0023
166 THALAMUS HAEMORRHAGE 2 0.0023
167 MENINGITIS CRYPTOCOCCAL 4 0.0023
168 MYELODYSPLASTIC SYNDROME 33 0.0023
169 BACTERIAL TEST POSITIVE 5 0.0022
170 BLOOD MAGNESIUM INCREASED 2 0.0022
171 ANGIOSARCOMA 1 0.0022
172 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
173 OVARIAN DISORDER 2 0.0021
174 INFUSION SITE HAEMATOMA 1 0.0021
175 TUMOUR HAEMORRHAGE 6 0.0021
176 HYPERVIGILANCE 2 0.0021
177 EVANS SYNDROME 1 0.0020
178 HEMIANOPIA 2 0.0020
179 MUCOSAL ULCERATION 2 0.0020
180 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
181 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
182 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
183 DIVERTICULAR PERFORATION 4 0.0019
184 METASTASES TO SKIN 2 0.0019
185 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
186 TUMOUR NECROSIS 2 0.0019
187 LEUKOENCEPHALOPATHY 7 0.0019
188 B-CELL LYMPHOMA RECURRENT 1 0.0018
189 OPTIC ATROPHY 3 0.0018
190 OCULAR TOXICITY 2 0.0018
191 BLOOD PH INCREASED 1 0.0018
192 SUSPECTED OFF LABEL USE 8 0.0018
193 NEOPLASM RECURRENCE 6 0.0018
194 BLOOD PH DECREASED 3 0.0018
195 ENANTHEMA 1 0.0017
196 CYSTITIS HAEMORRHAGIC 7 0.0017
197 CEREBRAL VENTRICLE DILATATION 2 0.0017
198 EOSINOPHIL COUNT DECREASED 4 0.0017
199 DERMO-HYPODERMITIS 1 0.0017
200 THROMBOCYTOPENIA 187 0.0017
201 MONOCYTE COUNT INCREASED 6 0.0017
202 PHARYNGEAL INFLAMMATION 2 0.0016
203 HOSPICE CARE 16 0.0016
204 WHITE BLOOD CELLS URINE POSITIVE 3 0.0016
205 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
206 BONE MARROW FAILURE 32 0.0016
207 BODY HEIGHT BELOW NORMAL 1 0.0016
208 PLATELET TRANSFUSION 2 0.0016
209 ENTEROCOCCUS TEST POSITIVE 1 0.0015
210 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
211 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
212 GRAFT VERSUS HOST DISEASE 11 0.0015
213 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
214 MUCOSAL INFLAMMATION 39 0.0015
215 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
216 BLOOD SODIUM INCREASED 4 0.0015
217 ABSCESS NECK 1 0.0015
218 BRAIN CANCER METASTATIC 1 0.0014
219 GASTROINTESTINAL PERFORATION 6 0.0014
220 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
221 HEMIPARESIS 24 0.0014
222 JAUNDICE CHOLESTATIC 5 0.0014
223 LYMPHOPENIA 20 0.0014
224 PULMONARY TOXICITY 10 0.0014
225 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
226 RETINAL VEIN OCCLUSION 4 0.0014
227 HODGKIN'S DISEASE 1 0.0014
228 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
229 HEMIANOPIA HOMONYMOUS 1 0.0014
230 COLITIS ISCHAEMIC 9 0.0013
231 EMBOLISM 11 0.0013
232 NEOPLASM PROGRESSION 46 0.0013
233 EMBOLISM VENOUS 4 0.0013
234 BRAIN OPERATION 3 0.0013
235 NEUROTOXICITY 23 0.0013
236 DYSAESTHESIA 4 0.0013
237 COAGULATION TEST ABNORMAL 1 0.0013
238 NEUROLOGICAL DECOMPENSATION 3 0.0013
239 BLOOD KETONE BODY INCREASED 1 0.0013
240 SKIN ABRASION 6 0.0013
241 BLOOD FIBRINOGEN INCREASED 1 0.0013
242 HEAT EXHAUSTION 1 0.0012
243 REBOUND EFFECT 14 0.0012
244 IIIRD NERVE PARALYSIS 1 0.0012
245 ENTEROCOCCAL SEPSIS 1 0.0012
246 RECURRENT CANCER 5 0.0012
247 DISEASE PROGRESSION 144 0.0012
248 STRESS CARDIOMYOPATHY 7 0.0012
249 PROTEIN URINE PRESENT 6 0.0012
250 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
251 FEBRILE BONE MARROW APLASIA 5 0.0012
252 ABSCESS LIMB 5 0.0012
253 GINGIVAL ERYTHEMA 1 0.0012
254 TREATMENT DELAYED 2 0.0012
255 GASTROINTESTINAL FISTULA 1 0.0011
256 DYSPHEMIA 5 0.0011
257 FOLLICULAR LYMPHOMA 1 0.0011
258 CEREBELLAR ATROPHY 1 0.0011
259 JAW OPERATION 1 0.0011
260 METASTASIS 8 0.0011
261 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
262 HYDROCEPHALUS 6 0.0011
263 RED BLOOD CELL COUNT INCREASED 3 0.0011
264 PNEUMONIA KLEBSIELLA 2 0.0011
265 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
266 ENTEROCOLITIS INFECTIOUS 1 0.0011
267 RASH MORBILLIFORM 3 0.0011
268 RETINOPATHY 4 0.0011
269 PLATELET COUNT DECREASED 114 0.0011
270 RENAL TUBULAR DISORDER 3 0.0011
271 INTRACRANIAL MASS 1 0.0011
272 CEREBELLAR ATAXIA 1 0.0010
273 BONE MARROW DEPRESSION 1 0.0010
274 IDIOSYNCRATIC DRUG REACTION 1 0.0010
275 GENE MUTATION 2 0.0010
276 CELL DEATH 2 0.0010
277 TRICUSPID VALVE INCOMPETENCE 8 0.0010
278 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
279 CRANIOCEREBRAL INJURY 3 0.0010
280 HYPOGONADISM 1 0.0010
281 NEUTROPENIA 134 0.0010
282 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
283 VISUAL FIELD DEFECT 7 0.0010
284 CHOLANGITIS 6 0.0010
285 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
286 APLASTIC ANAEMIA 5 0.0010
287 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
288 BLAST CELL COUNT INCREASED 1 0.0010
289 INCONTINENCE 10 0.0009
290 BONE DEMINERALISATION 1 0.0009
291 ATAXIA 11 0.0009
292 HEPATITIS ACUTE 6 0.0009
293 DEAFNESS UNILATERAL 5 0.0009
294 CHOLESTATIC LIVER INJURY 2 0.0009
295 CARDIAC HYPERTROPHY 1 0.0009
296 CYTOGENETIC ABNORMALITY 1 0.0009
297 GASTRIC POLYPS 2 0.0009
298 SKIN TOXICITY 5 0.0009
299 URINE ABNORMALITY 4 0.0009
300 NEUTROPHIL COUNT INCREASED 9 0.0009
301 ARTERIAL HAEMORRHAGE 1 0.0009
302 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
303 DYSLEXIA 1 0.0009
304 HEPATIC CYTOLYSIS 11 0.0009
305 HEPATOTOXICITY 19 0.0009
306 CARDIAC TAMPONADE 4 0.0008
307 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
308 PYODERMA GANGRENOSUM 3 0.0008
309 EMBOLISM ARTERIAL 1 0.0008
310 SLOW SPEECH 2 0.0008
311 THROMBOCYTOSIS 3 0.0008
312 FEBRILE NEUTROPENIA 54 0.0008
313 THERAPY CHANGE 8 0.0008
314 BODY TEMPERATURE DECREASED 8 0.0008
315 HYPERNATRAEMIA 4 0.0008
316 SEIZURE 92 0.0008
317 LYMPHOCYTE COUNT DECREASED 14 0.0008
318 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
319 FAILURE TO THRIVE 4 0.0008
320 EPIGASTRIC DISCOMFORT 3 0.0008
321 PARTIAL SEIZURES 4 0.0008
322 ACQUIRED GENE MUTATION 1 0.0008
323 POLYNEUROPATHY 9 0.0008
324 WHITE BLOOD CELL DISORDER 2 0.0007
325 TYPE 2 DIABETES MELLITUS 25 0.0007
326 PROTEINURIA 14 0.0007
327 PULMONARY THROMBOSIS 8 0.0007
328 DISCHARGE 1 0.0007
329 LARGE INTESTINE PERFORATION 5 0.0007
330 HYPERTRANSAMINASAEMIA 5 0.0007
331 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
332 JOINT INSTABILITY 1 0.0007
333 MALIGNANT NEOPLASM PROGRESSION 73 0.0007
334 MITRAL VALVE INCOMPETENCE 8 0.0007
335 APPENDIX DISORDER 1 0.0007
336 PERONEAL NERVE PALSY 4 0.0007
337 NEOPLASM 8 0.0007
338 TOXIC SKIN ERUPTION 7 0.0007
339 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
340 GASTROINTESTINAL NECROSIS 2 0.0007
341 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
342 LEUKOPENIA 34 0.0007
343 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
344 CEREBRAL DISORDER 5 0.0007
345 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
346 PANCYTOPENIA 37 0.0007
347 PLATELET COUNT ABNORMAL 4 0.0007
348 ASTIGMATISM 1 0.0007
349 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
350 CYTOPENIA 8 0.0007
351 MASTICATION DISORDER 2 0.0007
352 BRAIN NEOPLASM 6 0.0007
353 MULTIPLE-DRUG RESISTANCE 2 0.0006
354 VAGINAL INFECTION 3 0.0006
355 BRAIN OEDEMA 8 0.0006
356 RED BLOOD CELL COUNT DECREASED 18 0.0006
357 JC VIRUS INFECTION 1 0.0006
358 LOOSE TOOTH 2 0.0006
359 COLON CANCER METASTATIC 1 0.0006
360 CARDIOMYOPATHY 9 0.0006
361 ORGANISING PNEUMONIA 3 0.0006
362 APPETITE DISORDER 4 0.0006
363 HEPATIC ENZYME ABNORMAL 3 0.0006
364 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
365 FULL BLOOD COUNT DECREASED 12 0.0006
366 HEPATORENAL SYNDROME 1 0.0006
367 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
368 WOUND DEHISCENCE 2 0.0006
369 LEUKAEMIA RECURRENT 1 0.0006
370 DEAFNESS BILATERAL 1 0.0006
371 CACHEXIA 3 0.0006
372 VIITH NERVE PARALYSIS 2 0.0006
373 BLOOD CHLORIDE INCREASED 1 0.0006
374 OSTEONECROSIS 19 0.0006
375 HYPOPITUITARISM 1 0.0006
376 EXTREMITY NECROSIS 1 0.0006
377 FULL BLOOD COUNT ABNORMAL 6 0.0006
378 NYSTAGMUS 3 0.0006
379 JUGULAR VEIN THROMBOSIS 1 0.0006
380 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
381 APPLICATION SITE DISCOMFORT 1 0.0006
382 HAEMATOCRIT DECREASED 11 0.0006
383 WHITE BLOOD CELL COUNT DECREASED 60 0.0006
384 BLOOD PHOSPHORUS DECREASED 2 0.0005
385 GRANULOCYTE COUNT DECREASED 1 0.0005
386 NECROSIS 3 0.0005
387 BLOOD BICARBONATE DECREASED 1 0.0005
388 HYPERTHERMIA 4 0.0005
389 EXERCISE TOLERANCE DECREASED 3 0.0005
390 ARTERIAL THROMBOSIS 1 0.0005
391 HYPOALBUMINAEMIA 4 0.0005
392 CARDIOPULMONARY FAILURE 2 0.0005
393 VENOUS THROMBOSIS 2 0.0005
394 COORDINATION ABNORMAL 7 0.0005
395 CEREBRAL ATROPHY 2 0.0005
396 HYPOPHYSITIS 1 0.0005
397 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
398 COGNITIVE DISORDER 23 0.0005
399 NEUTROPHIL COUNT DECREASED 20 0.0005
400 MOTOR DYSFUNCTION 5 0.0005
401 LIVER INJURY 12 0.0005
402 CAPILLARY LEAK SYNDROME 1 0.0005
403 OLIGURIA 3 0.0005
404 HYPERBILIRUBINAEMIA 5 0.0005
405 SEPTIC SHOCK 21 0.0005
406 DEVICE MATERIAL ISSUE 1 0.0005
407 EAR SWELLING 1 0.0005
408 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
409 PULMONARY FIBROSIS 9 0.0005
410 ENTERITIS 3 0.0005
411 CD4 LYMPHOCYTES DECREASED 1 0.0005
412 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
413 JAW FRACTURE 1 0.0005
414 LANGUAGE DISORDER 1 0.0005
415 HEART RATE DECREASED 16 0.0005
416 GINGIVAL SWELLING 2 0.0005
417 PULMONARY EMBOLISM 43 0.0005
418 PURPURA 4 0.0005
419 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
420 MALNUTRITION 5 0.0004
421 MYELOSUPPRESSION 16 0.0004
422 NEPHROTIC SYNDROME 3 0.0004
423 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
424 IMMUNE THROMBOCYTOPENIA 2 0.0004
425 ISCHAEMIA 2 0.0004
426 CYTOMEGALOVIRUS COLITIS 1 0.0004
427 HAIR GROWTH ABNORMAL 3 0.0004
428 ORAL DISCOMFORT 6 0.0004
429 APHASIA 13 0.0004
430 DRUG RESISTANCE 11 0.0004
431 HEPATOCELLULAR INJURY 6 0.0004
432 SPEECH DISORDER 22 0.0004
433 HYPOVOLAEMIC SHOCK 2 0.0004
434 NON-SMALL CELL LUNG CANCER 2 0.0004
435 CHOLESTASIS 8 0.0004
436 ACUTE RESPIRATORY FAILURE 8 0.0004
437 RENAL CELL CARCINOMA 2 0.0004
438 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
439 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
440 NEUROPATHY PERIPHERAL 38 0.0004
441 DYSARTHRIA 15 0.0004
442 ERYSIPELAS 2 0.0004
443 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
444 EXCORIATION 1 0.0004
445 HAEMORRHAGE URINARY TRACT 1 0.0004
446 THERAPY CESSATION 20 0.0004
447 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
448 THERAPY PARTIAL RESPONDER 6 0.0004
449 HEPATITIS TOXIC 1 0.0004
450 DEAFNESS 10 0.0004
451 FRUSTRATION TOLERANCE DECREASED 3 0.0004
452 GINGIVITIS 2 0.0004
453 LARGE INTESTINAL ULCER 1 0.0004
454 CONVULSION 21 0.0004
455 HICCUPS 3 0.0004
456 HYPERAESTHESIA 3 0.0004
457 INTESTINAL ISCHAEMIA 2 0.0004
458 HEMIPLEGIA 3 0.0004
459 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
460 CEREBRAL THROMBOSIS 1 0.0004
461 NEUROLOGICAL SYMPTOM 2 0.0003
462 PSEUDOMONAS INFECTION 3 0.0003
463 PARALYSIS 5 0.0003
464 ENTEROCOLITIS 2 0.0003
465 METASTASES TO LUNG 4 0.0003
466 ESCHERICHIA SEPSIS 1 0.0003
467 ADENOVIRUS INFECTION 1 0.0003
468 LIVER FUNCTION TEST ABNORMAL 10 0.0003
469 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
470 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
471 HYPERTRIGLYCERIDAEMIA 2 0.0003
472 ANAEMIA 65 0.0003
473 GROWTH RETARDATION 1 0.0003
474 PLEURISY 2 0.0003
475 DISEASE RECURRENCE 16 0.0003
476 CONSTIPATION 73 0.0003
477 HAEMORRHAGE INTRACRANIAL 5 0.0003
478 BLOOD BILIRUBIN INCREASED 9 0.0003
479 CEREBROVASCULAR DISORDER 1 0.0003
480 SEPSIS 37 0.0003
481 BONE MARROW DISORDER 1 0.0003
482 PATHOGEN RESISTANCE 3 0.0003
483 DRUG DISPENSING ERROR 5 0.0003
484 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
485 MENTAL STATUS CHANGES 9 0.0003
486 HYPERCALCAEMIA 4 0.0003
487 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
488 INFUSION SITE EXTRAVASATION 2 0.0003
489 SQUAMOUS CELL CARCINOMA 3 0.0003
490 MELAENA 7 0.0003
491 DEATH 273 0.0003
492 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
493 HYPOTHYROIDISM 10 0.0003
494 PRODUCT USE IN UNAPPROVED INDICATION 77 0.0003
495 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
496 LYMPHOCYTE COUNT INCREASED 1 0.0003
497 HYPOGAMMAGLOBULINAEMIA 2 0.0003
498 HYPOKALAEMIA 14 0.0003
499 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
500 CYTOLYTIC HEPATITIS 1 0.0003
501 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
502 JAUNDICE 8 0.0003
503 BK VIRUS INFECTION 1 0.0003
504 CLOSTRIDIAL INFECTION 1 0.0003
505 ULCER HAEMORRHAGE 2 0.0003
506 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
507 CIRCULATORY COLLAPSE 5 0.0003
508 NAUSEA 232 0.0003
509 EYE MOVEMENT DISORDER 2 0.0003
510 BLOOD PRESSURE FLUCTUATION 7 0.0003
511 OFF LABEL USE 254 0.0003
512 RESPIRATORY DISTRESS 8 0.0003
513 MULTI-ORGAN FAILURE 5 0.0003
514 ENCEPHALITIS 2 0.0003
515 LARGE INTESTINE POLYP 2 0.0003
516 HYPERREFLEXIA 1 0.0003
517 BLOOD TEST ABNORMAL 4 0.0003
518 INFECTION 41 0.0003
519 FACIAL PARESIS 1 0.0003
520 FATIGUE 219 0.0003
521 NEUTROPENIC SEPSIS 2 0.0003
522 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
523 DERMATITIS BULLOUS 2 0.0003
524 FOOD INTOLERANCE 1 0.0003
525 MOUTH HAEMORRHAGE 2 0.0003
526 HAEMOGLOBIN DECREASED 28 0.0003
527 HYPOPHOSPHATAEMIA 2 0.0003
528 NEPHROPATHY TOXIC 3 0.0003
529 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
530 HEPATIC ENZYME INCREASED 18 0.0003
531 LOSS OF CONTROL OF LEGS 1 0.0003
532 STOMATITIS 16 0.0003
533 SCAB 3 0.0003
534 THROMBOSIS 21 0.0003
535 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
536 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
537 BLOOD ALBUMIN DECREASED 2 0.0003
538 CEREBRAL HAEMORRHAGE 9 0.0003
539 MOBILITY DECREASED 18 0.0003
540 SENSORY LOSS 2 0.0002
541 NIGHT SWEATS 8 0.0002
542 POST PROCEDURAL INFECTION 2 0.0002
543 METASTASES TO BONE 4 0.0002
544 ESCHERICHIA INFECTION 2 0.0002
545 AORTIC DISSECTION 1 0.0002
546 BLOOD UREA INCREASED 4 0.0002
547 HYPERPYREXIA 1 0.0002
548 DIABETES MELLITUS 18 0.0002
549 AORTIC VALVE INCOMPETENCE 1 0.0002
550 HEPATITIS 6 0.0002
551 VOMITING 110 0.0002
552 HORDEOLUM 1 0.0002
553 EPILEPSY 7 0.0002
554 DECREASED APPETITE 53 0.0002
555 ORAL CANDIDIASIS 3 0.0002
556 TUMOUR LYSIS SYNDROME 2 0.0002
557 BLOOD CREATINE INCREASED 1 0.0002
558 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
559 CARDIOTOXICITY 2 0.0002
560 ILEUS PARALYTIC 1 0.0002
561 OROPHARYNGEAL DISCOMFORT 2 0.0002
562 BLINDNESS 9 0.0002
563 URTICARIA 37 0.0002
564 DISEASE COMPLICATION 1 0.0002
565 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
566 SHOCK 5 0.0002
567 IRON DEFICIENCY ANAEMIA 2 0.0002
568 CHRONIC MYELOID LEUKAEMIA 1 0.0002
569 PERICARDIAL EFFUSION 5 0.0002
570 HEPATIC STEATOSIS 4 0.0002
571 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
572 OXYGEN SATURATION DECREASED 12 0.0002
573 PHOTOPHOBIA 4 0.0002
574 PAIN IN JAW 6 0.0002
575 SUBDURAL HAEMATOMA 3 0.0002
576 POST PROCEDURAL COMPLICATION 4 0.0002
577 GASTROINTESTINAL TOXICITY 1 0.0002
578 GUILLAIN-BARRE SYNDROME 1 0.0002
579 THROMBOTIC MICROANGIOPATHY 2 0.0002
580 ENCEPHALOPATHY 5 0.0002
581 LABORATORY TEST ABNORMAL 6 0.0002
582 TOXICITY TO VARIOUS AGENTS 34 0.0002
583 IMMUNODEFICIENCY 3 0.0002
584 PNEUMONIA ASPIRATION 5 0.0002
585 DEEP VEIN THROMBOSIS 13 0.0002
586 HYPERAMMONAEMIA 1 0.0002
587 FLUID INTAKE REDUCED 1 0.0002
588 DERMATITIS EXFOLIATIVE 1 0.0002
589 BRAIN INJURY 2 0.0002
590 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
591 TASTE DISORDER 4 0.0002
592 WEIGHT DECREASED 55 0.0002
593 ENDOCARDITIS 1 0.0002
594 THYROID DISORDER 3 0.0002
595 POOR VENOUS ACCESS 2 0.0002
596 DRUG EFFECT INCOMPLETE 7 0.0002
597 ACCIDENTAL OVERDOSE 7 0.0002
598 MOVEMENT DISORDER 6 0.0002
599 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
600 LIVER FUNCTION TEST INCREASED 4 0.0002
601 BEHAVIOUR DISORDER 1 0.0002
602 CHEILITIS 1 0.0002
603 PALLOR 5 0.0002
604 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
605 WOUND INFECTION 2 0.0002
606 MANIA 3 0.0002
607 HYPERKERATOSIS 1 0.0002
608 CYTOMEGALOVIRUS INFECTION 3 0.0002
609 NERVE INJURY 2 0.0002
610 NEOPLASM MALIGNANT 12 0.0002
611 PLASMA CELL MYELOMA 7 0.0002
612 ANGIOPATHY 1 0.0002
613 ACUTE PULMONARY OEDEMA 1 0.0002
614 CANDIDA INFECTION 3 0.0002
615 HYPONATRAEMIA 10 0.0002
616 STATUS EPILEPTICUS 2 0.0002
617 CARDIAC VALVE DISEASE 1 0.0002
618 EPISTAXIS 13 0.0002
619 BALANCE DISORDER 15 0.0002
620 BLOOD URIC ACID INCREASED 1 0.0002
621 DYSPHONIA 10 0.0002
622 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
623 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
624 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
625 BLOOD CREATININE INCREASED 11 0.0002
626 HEPATIC FAILURE 5 0.0002
627 HYPERGLYCAEMIA 6 0.0002
628 NEURALGIA 4 0.0002
629 NO THERAPEUTIC RESPONSE 2 0.0002
630 AGITATION 12 0.0002
631 LUNG DISORDER 8 0.0002
632 TOOTH EXTRACTION 2 0.0002
633 ASTHENIA 60 0.0002
634 MUSCULAR WEAKNESS 18 0.0002
635 COLITIS 6 0.0002
636 LIVER DISORDER 7 0.0002
637 DEHYDRATION 21 0.0002
638 FOREIGN BODY SENSATION IN EYES 1 0.0002
639 HERPES ZOSTER 9 0.0002
640 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
641 HAEMOGLOBIN ABNORMAL 1 0.0002
642 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
643 INCOHERENT 1 0.0002
644 RASH GENERALISED 4 0.0002
645 LACTIC ACIDOSIS 5 0.0002
646 HYPOAESTHESIA 23 0.0002
647 PARAESTHESIA 24 0.0002
648 ASPERGILLUS INFECTION 1 0.0002
649 IMPAIRED HEALING 5 0.0002
650 IMMUNE SYSTEM DISORDER 2 0.0002
651 CARDIAC FAILURE ACUTE 1 0.0001
652 GAIT INABILITY 5 0.0001
653 PRODUCT USE ISSUE 28 0.0001
654 PNEUMONIA 48 0.0001
655 ACUTE HEPATIC FAILURE 2 0.0001
656 GAIT DISTURBANCE 28 0.0001
657 TREATMENT FAILURE 12 0.0001
658 HYPOMAGNESAEMIA 2 0.0001
659 APHONIA 2 0.0001
660 MOUTH ULCERATION 3 0.0001
661 ABDOMINAL PAIN 33 0.0001
662 PYREXIA 49 0.0001
663 THERAPY INTERRUPTED 10 0.0001
664 RECTAL HAEMORRHAGE 6 0.0001
665 HYPERSOMNIA 4 0.0001
666 HEADACHE 87 0.0001
667 PRURITUS GENERALISED 3 0.0001
668 AMNESIA 9 0.0001
669 HYPOKINESIA 2 0.0001
670 PRODUCT DISPENSING ERROR 3 0.0001
671 PRODUCT PRESCRIBING ISSUE 3 0.0001
672 BLOOD PRESSURE INCREASED 21 0.0001
673 CONFUSIONAL STATE 22 0.0001
674 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
675 CONTUSION 13 0.0001
676 ARTHROPOD BITE 1 0.0001
677 RASH MACULO-PAPULAR 3 0.0001
678 GLOSSODYNIA 3 0.0001
679 ORAL PAIN 3 0.0001
680 HEPATIC FUNCTION ABNORMAL 5 0.0001
681 THERAPY NON-RESPONDER 6 0.0001
682 RASH 58 0.0001
683 HYPERTENSION 28 0.0001
684 HAEMODYNAMIC INSTABILITY 1 0.0001
685 RENAL IMPAIRMENT 11 0.0001
686 ACIDOSIS 1 0.0001
687 LIPASE INCREASED 1 0.0001
688 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
689 ATRIOVENTRICULAR BLOCK 1 0.0001
690 VISUAL IMPAIRMENT 16 0.0001
691 OEDEMA 7 0.0001
692 LUNG INFECTION 2 0.0001
693 APNOEA 1 0.0001
694 GASTROINTESTINAL INFLAMMATION 1 0.0001
695 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
696 ULCER 2 0.0001
697 GINGIVAL PAIN 1 0.0001
698 BLOOD DISORDER 1 0.0001
699 RESPIRATORY FAILURE 9 0.0001
700 ATRIAL FIBRILLATION 12 0.0001
701 ACUTE CORONARY SYNDROME 1 0.0001
702 SKIN DISORDER 4 0.0001
703 BONE PAIN 7 0.0001
704 HAEMODIALYSIS 1 0.0001
705 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
706 HAEMATEMESIS 3 0.0001
707 ANGER 4 0.0001
708 CARDIOVASCULAR DISORDER 3 0.0001
709 HYPOPHAGIA 3 0.0001
710 FACIAL PARALYSIS 1 0.0001
711 HOSPITALISATION 18 0.0001
712 ANURIA 1 0.0001
713 HYPOACUSIS 5 0.0001
714 ILL-DEFINED DISORDER 7 0.0001
715 GASTRITIS 3 0.0001
716 HYPOXIA 4 0.0001
717 IMMUNOSUPPRESSION 1 0.0001
718 LUNG INFILTRATION 1 0.0001
719 GASTROINTESTINAL INFECTION 1 0.0001
720 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
721 ANAL INCONTINENCE 1 0.0001
722 DEVELOPMENTAL DELAY 1 0.0001
723 LEUKOCYTOSIS 2 0.0001
724 RESTLESS LEGS SYNDROME 2 0.0001
725 C-REACTIVE PROTEIN INCREASED 4 0.0001
726 BONE DISORDER 2 0.0001
727 AGRANULOCYTOSIS 2 0.0001
728 HEPATIC ENCEPHALOPATHY 1 0.0001
729 APPENDICITIS 1 0.0001
730 BLISTER 6 0.0001
731 LACERATION 1 0.0001
732 ARTERIOSCLEROSIS 1 0.0001
733 ABORTION INDUCED 1 0.0001
734 BLOOD SODIUM DECREASED 2 0.0001
735 HYPOCALCAEMIA 2 0.0001
736 FRACTURE 2 0.0001
737 INFUSION RELATED REACTION 7 0.0001
738 DIARRHOEA 68 0.0001
739 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
740 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
741 HYPERCHOLESTEROLAEMIA 1 0.0001
742 DYSSTASIA 3 0.0001
743 HEPATOMEGALY 1 0.0001
744 ACUTE MYOCARDIAL INFARCTION 3 0.0001
745 PSYCHOTIC DISORDER 3 0.0001
746 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
747 BLOOD PRESSURE ABNORMAL 2 0.0001
748 HYPOTONIA 1 0.0001
749 DRY MOUTH 8 0.0001
750 EYELID PTOSIS 1 0.0001
751 BODY TEMPERATURE INCREASED 2 0.0001
752 INITIAL INSOMNIA 1 0.0001
753 NERVOUS SYSTEM DISORDER 3 0.0001
754 HAEMORRHAGE 10 0.0001
755 DRUG-INDUCED LIVER INJURY 3 0.0001
756 DRUG INEFFECTIVE 126 0.0001
757 FOLLICULITIS 1 0.0001
758 SOMNOLENCE 19 0.0001
759 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
760 BRADYCARDIA 5 0.0001
761 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
762 SWELLING FACE 6 0.0001
763 ACUTE KIDNEY INJURY 14 0.0001
764 CHOLELITHIASIS 3 0.0001
765 BLOOD GLUCOSE FLUCTUATION 1 0.0001
766 HEART RATE INCREASED 9 0.0001
767 DENTAL CARIES 1 0.0001
768 VIRAL INFECTION 3 0.0001
769 PANCREATITIS ACUTE 2 0.0001
770 FISTULA 1 0.0001
771 BLOOD CALCIUM DECREASED 1 0.0001
772 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
773 INTERNAL HAEMORRHAGE 1 0.0001
774 TINNITUS 4 0.0001
775 OROPHARYNGEAL PAIN 8 0.0001
776 CHILLS 10 0.0001
777 HYPOTENSION 17 0.0001
778 DYSPHAGIA 8 0.0001
779 HYPERLIPIDAEMIA 1 0.0001
780 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
781 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
782 DRUG INTOLERANCE 8 0.0001
783 LOCALISED INFECTION 2 0.0001
784 ADRENAL INSUFFICIENCY 1 0.0001
785 CEREBRAL INFARCTION 2 0.0001
786 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
787 CARDIOMEGALY 1 0.0001
788 INJECTION SITE EXTRAVASATION 1 0.0001
789 CYST 1 0.0001
790 APPLICATION SITE IRRITATION 1 0.0001
791 DYSPNOEA EXERTIONAL 3 0.0001
792 ACNE 6 0.0001
793 FALL 26 0.0001
794 ANOREXIA 1 0.0001
795 SKIN ULCER 2 0.0001
796 DIPLOPIA 2 0.0001
797 BEDRIDDEN 1 0.0001
798 ABNORMAL BEHAVIOUR 3 0.0001
799 DISORIENTATION 3 0.0001
800 HYPERSENSITIVITY 14 0.0001
801 ADVERSE REACTION 1 0.0001
802 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
803 RASH PRURITIC 4 0.0001
804 LIMB INJURY 2 0.0001
805 DRUG TOXICITY 1 0.0001
806 GINGIVAL BLEEDING 1 0.0001
807 MEMORY IMPAIRMENT 10 0.0001
808 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
809 APPLICATION SITE RASH 1 0.0001
810 TREMOR 12 0.0001
811 HAEMOPTYSIS 2 0.0001
812 NECK PAIN 4 0.0001
813 SLEEP DISORDER 5 0.0001
814 CEREBROVASCULAR ACCIDENT 12 0.0001
815 URINARY TRACT INFECTION 12 0.0001
816 PRURITUS 27 0.0001
817 CARDIOGENIC SHOCK 1 0.0001
818 IMPAIRED QUALITY OF LIFE 1 0.0001
819 INJECTION SITE HAEMATOMA 1 0.0001
820 APATHY 1 0.0001
821 ASCITES 2 0.0001
822 PRODUCT DOSE OMISSION ISSUE 20 0.0001
823 RENAL FAILURE 9 0.0001
824 RENAL INJURY 2 0.0001
825 DYSGEUSIA 5 0.0001
826 GASTROINTESTINAL DISORDER 6 0.0001
827 BONE LOSS 1 0.0001
828 LACRIMATION INCREASED 2 0.0001
829 ALOPECIA 13 0.0001
830 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
831 ECONOMIC PROBLEM 1 0.0001
832 PLEURAL EFFUSION 4 0.0001
833 OEDEMA PERIPHERAL 8 0.0001
834 ABDOMINAL DISCOMFORT 11 0.0001
835 SKIN IRRITATION 3 0.0001
836 INSURANCE ISSUE 1 0.0001
837 LYMPHOMA 1 0.0001
838 EJECTION FRACTION DECREASED 1 0.0001
839 BASAL CELL CARCINOMA 1 0.0001
840 BRAIN FOG 1 0.0001
841 CYANOSIS 1 0.0001
842 HEAD INJURY 2 0.0001
843 ABDOMINAL PAIN UPPER 13 0.0001
844 MIGRAINE 6 0.0001
845 CYSTITIS 2 0.0001
846 RASH ERYTHEMATOUS 3 0.0001
847 MOOD SWINGS 2 0.0001
848 COVID-19 11 0.0001
849 WEIGHT INCREASED 14 0.0001
850 BLOOD GLUCOSE DECREASED 3 0.0001
851 BLOOD POTASSIUM INCREASED 1 0.0001
852 DYSPEPSIA 6 0.0001
853 STAPHYLOCOCCAL INFECTION 2 0.0001
854 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
855 DRUG LEVEL INCREASED 1 0.0001
856 COAGULOPATHY 1 0.0001
857 NASOPHARYNGITIS 11 0.0001
858 FACE OEDEMA 1 0.0001
859 VISION BLURRED 8 0.0001
860 NIGHTMARE 2 0.0001
861 RASH MACULAR 2 0.0001
862 MUSCULOSKELETAL STIFFNESS 5 0.0001
863 EOSINOPHILIA 1 0.0001
864 MALAISE 25 0.0001
865 PANCREATITIS 3 0.0001
866 HEAD DISCOMFORT 1 0.0001
867 ISCHAEMIC STROKE 1 0.0001
868 CONDITION AGGRAVATED 17 0.0001
869 PANIC ATTACK 2 0.0001
870 DYSPNOEA 31 0.0001
871 RESTLESSNESS 2 0.0001
872 LOSS OF CONSCIOUSNESS 7 0.0001
873 HAEMATOCHEZIA 3 0.0001
874 ADVERSE EVENT 5 0.0001
875 DIZZINESS 27 0.0001
876 CONJUNCTIVITIS 1 0.0001
877 INFLUENZA 6 0.0001
878 BACTERIAL INFECTION 1 0.0001
879 SWELLING 5 0.0001
880 HALLUCINATION 4 0.0001
881 FLATULENCE 3 0.0001
882 INCREASED APPETITE 1 0.0001
883 PERIPHERAL SWELLING 8 0.0001
884 GLAUCOMA 1 0.0001
885 ARTHRALGIA 21 0.0001
886 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
887 PAIN 31 0.0001
888 CYTOKINE RELEASE SYNDROME 1 0.0000
889 THERAPEUTIC RESPONSE DECREASED 3 0.0000
890 FEEDING DISORDER 1 0.0000
891 SINUSITIS 5 0.0000
892 ERYTHEMA 10 0.0000
893 OSTEOPOROSIS 2 0.0000
894 POLLAKIURIA 2 0.0000
895 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
896 CARDIO-RESPIRATORY ARREST 2 0.0000
897 HALLUCINATION, VISUAL 1 0.0000
898 EATING DISORDER 1 0.0000
899 IMPAIRED WORK ABILITY 1 0.0000
900 RHINORRHOEA 3 0.0000
901 FAECES DISCOLOURED 1 0.0000
902 PRODUCT DOSE OMISSION 3 0.0000
903 APPLICATION SITE PAIN 1 0.0000
904 INSOMNIA 12 0.0000
905 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
906 CHROMATURIA 1 0.0000
907 APPLICATION SITE PRURITUS 1 0.0000
908 DEPRESSION 10 0.0000
909 INJECTION SITE REACTION 3 0.0000
910 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
911 RENAL DISORDER 2 0.0000
912 ANXIETY 12 0.0000
913 DIABETIC KETOACIDOSIS 1 0.0000
914 MYALGIA 7 0.0000
915 CELLULITIS 2 0.0000
916 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
917 FLUID RETENTION 2 0.0000
918 COUGH 11 0.0000
919 HAEMATOMA 1 0.0000
920 APPLICATION SITE ERYTHEMA 1 0.0000
921 MUSCLE SPASMS 7 0.0000
922 JOINT STIFFNESS 1 0.0000
923 ANHEDONIA 1 0.0000
924 DRY SKIN 5 0.0000
925 CARDIAC FAILURE 3 0.0000
926 DRUG EFFECT DECREASED 2 0.0000
927 OVERDOSE 8 0.0000
928 INFLUENZA LIKE ILLNESS 3 0.0000
929 DIVERTICULITIS 1 0.0000
930 ARTHROPATHY 2 0.0000
931 FEELING COLD 1 0.0000
932 DEMENTIA 1 0.0000
933 EYE PAIN 2 0.0000
934 ANGINA PECTORIS 1 0.0000
935 LETHARGY 2 0.0000
936 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
937 BACK PAIN 8 0.0000
938 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
939 NASAL CONGESTION 2 0.0000
940 ADVERSE DRUG REACTION 3 0.0000
941 IRRITABILITY 2 0.0000
942 BLOOD POTASSIUM DECREASED 1 0.0000
943 NO ADVERSE EVENT 6 0.0000
944 VERTIGO 2 0.0000
945 DISCOMFORT 2 0.0000
946 DRUG ADMINISTRATION ERROR 1 0.0000
947 LIMB DISCOMFORT 1 0.0000
948 CARDIAC DISORDER 3 0.0000
949 BLOOD GLUCOSE INCREASED 6 0.0000
950 DRUG INTERACTION 5 0.0000
951 PAIN IN EXTREMITY 9 0.0000
952 EYE DISORDER 1 0.0000
953 BLOOD PRESSURE DECREASED 2 0.0000
954 EXPIRED PRODUCT ADMINISTERED 1 0.0000
955 LIP SWELLING 1 0.0000
956 SYNCOPE 3 0.0000
957 FLUSHING 3 0.0000
958 FEELING ABNORMAL 7 0.0000
959 HAEMATURIA 1 0.0000
960 HYPERKALAEMIA 1 0.0000
961 LYMPHADENOPATHY 1 0.0000
962 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
963 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
964 SKIN BURNING SENSATION 2 0.0000
965 INTESTINAL OBSTRUCTION 1 0.0000
966 UNEVALUABLE EVENT 2 0.0000
967 EMOTIONAL DISTRESS 3 0.0000
968 CARDIAC ARREST 2 0.0000
969 DRUG DOSE OMISSION 4 0.0000
970 SKIN EXFOLIATION 2 0.0000
971 CHEST PAIN 4 0.0000
972 BLOOD CHOLESTEROL INCREASED 1 0.0000
973 COLORECTAL CANCER 1 0.0000
974 INTERSTITIAL LUNG DISEASE 1 0.0000
975 AGGRESSION 1 0.0000
976 INFLAMMATION 1 0.0000
977 ANAPHYLACTIC REACTION 1 0.0000
978 ASTHMA 2 0.0000
979 INCORRECT DOSE ADMINISTERED 4 0.0000
980 JOINT SWELLING 2 0.0000
981 EXPOSURE DURING PREGNANCY 1 0.0000
982 BURNING SENSATION 1 0.0000
983 INJURY 1 0.0000
984 BRONCHITIS 1 0.0000
985 CHRONIC KIDNEY DISEASE 1 0.0000
986 MYOCARDIAL INFARCTION 2 0.0000
987 CHEST DISCOMFORT 1 0.0000
988 ILLNESS 1 0.0000
989 ABDOMINAL DISTENSION 1 0.0000